Two generic drug makers will pay Pfizer and Takeda Pharmaceutical $2.15 billion for producing generic versions of a heartburn drug before its patent expired. More
- ADVERTISEMENT
-
Sponsored By:
-
Sponsored By:
- Poll of the Day
- Partners
- ADVERTISEMENT
- More Financial News

















